1. Pain 2. Depression 3. Anxiety Mental and Behavioural Disorders 1. Pain 2. Depression 3. Anxiety
Conditions
Interventions
All participants receive the transdiagnostic Internet-based CBT, a T-ICBT program designed to treat symptoms of anxiety and depression among adults who have difficulty coping with chronic pain. The pr
Sponsors
University of Regina
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Resident of Saskatchewan 2. Aged 18 years or older 3. Currently experiencing pain for at least the past 3 months 4. Has had pain assessed by a physician or specialist within last 3 months 5. Experiencing symptoms of depression and/or anxiety 6. Has access to a computer and the Internet 7. Has an interest in the Pain Course
Exclusion criteria
Exclusion criteria: 1. Not a resident of Saskatchewan 2. Less than 18 years of age 3. Has no regular access to a computer, Internet, and use of printer 4. Is unwilling to have their physician, a medical clinic, or an emergency hospital be notified of their participation in the program 5. High current risk of suicide or attempt in past year 6. Past or present diagnosis of schizophrenia or psychotic disorder 7. Alcohol or drug problem that requires primary treatment 8. Hospitalization for mental health problem in past year 9. Does not complete online or telephone screening 10. Does not consent to treatment or complete pre-treatment questionnaires
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Current secondary outcome measures as of 26/11/2020: 1. Pain related disability and interference is measured using the Brief Pain Inventory (BPI) at baseline, immediately following completion of the program (8 weeks), and 3 months 2. Pain self-efficacy is measured using the Pain Self-efficacy Questionnaire (PSEQ) at baseline, immediately following completion of the program (8 weeks), and 3 months 3. Fears of movement and re-injury are measured using theTAMPA Scale of Kinesiophobia (TSK) at baseline, immediately following completion of the program (8 weeks), and 3 months 4. Chronic Pain Acceptance Questionnaire CPAQ-8 at baseline, immediately following completion of the program (8 weeks), and 3 months 5. Pain Medication is determined using an open-ended question which asks participants to list the depression, anxiety, or pain medication that they are currently taking at baseline, immediately following completion of the program (8 weeks), and 3 months 6. Health Service Utilization is determined using open-ended questions which ask participants to list the total number of visits to a variety of health professionals because of symptoms of anxiety, depression, or pain at baseline, immediately following completion of the program (8 weeks), and 3 months _____ Previous secondary outcome measures: 1. Pain related disability and interference is measured using the Brief Pain Inventory (BPI) at baseline, immediately following completion of the program (8 weeks), and 3 months 2. Pain self-efficacy is measured using the Pain Self-efficacy Questionnaire (PSEQ) at baseline, immediately following completion of the program (8 weeks), and 3 months 3. Fears of movement and re-injury are measured using theTAMPA Scale of Kinesiophobia (TSK) at baseline, immediately following completion of the program (8 w | — |
Primary
| Measure | Time frame |
|---|---|
| 1. Depressive symptoms are measured using the Patient Health Questionnaire- 9 Item (PHQ-9) at baseline, immediately following completion of the program (8 weeks), and 3 months 2. Symptoms of generalized anxiety are measured using the Generalized Anxiety Disorder -7 Item (GAD-7) at baseline, immediately following completion of the program (8 weeks), and 3 months 3. Disability associated with chronic pain is measured using the Roland Morris Disability Questionnaire (RMDQ) at baseline, immediately following completion of the program (8 weeks), and 3 months | — |
Countries
Canada
Outcome results
None listed